drugset / Trial / NCT02223078

Two Center Study to Determine Effect of G17DT on Plasma Gastrin Levels in Patients With Colorectal Cancer.

NCT02223078

Phase 2 Completed Cancer Advances Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

Pancreatic, gastric, and colorectal cancers have all been shown to overexpress the gastrin gene and to be sensitive to the trophic effects of the gastrin in animal models. The hypothesis of this study is that G17DT will elicit specific and high-affinity antibodies that will bind gastrin-17, thus preventing the trophic activity of cancer cells.

Timeline

Start
2000-07
Primary completion
2001-08
Completion
2001-11

Drugs

EvaluationDrugModalityDoseRoute
Subject G17DT Immunogen Vaccine 250 ug

Indications